Search results
Revolutionizing Cancer Treatment: Key to Prolonging CAR T Cell Life Uncovered
SciTechDaily· 3 days agoFOXO1 is required for T cell memory and is linked to longer-lasting clinical outcomes in CAR T cell ...
Immune cell discovery ‘could lead to personalised treatment for breast cancer’
PA Media: Science via Yahoo News· 10 hours ago“We need a greater understanding of how the immune system defends the body against cancer and most...
Testing for residual cancer cells before blood cell transplant therapy is important and practical,...
Medical Xpress· 10 hours agoThe finding appearing in JAMA Oncology emphasizes the importance and practicality of testing for...
Replay wins IND clearance for PRAME T cell cancer therapy
Clinical Trials Arena via Yahoo Finance· 1 day ago"Replay wins IND clearance for PRAME T cell cancer therapy" was originally created and published by...
Astellas and Poseida join forces for cancer cell therapy By Investing.com
Investing.com· 23 hours ago(TSE: 4503) and Poseida Therapeutics, Inc. (NASDAQ: PSTX) have entered a research collaboration and...
Xyphos and Poseida to develop allogeneic cell therapies for cancer
Pharmaceutical Technology via Yahoo Finance· 14 hours agoPoseida focuses on progressing cell and gene therapies that have the potential to cure certain ...
Do cutting-edge CAR-T-cell therapies cause cancer? What the data say
Nature· 3 days agoRegulators have identified around 30 cases of cancer linked to this blockbuster treatment. But is...
Researchers discover how immune B cells hunt down cancer around the body
Medical Xpress· 6 hours agoScientists at the University of Oxford's Department of Biochemistry, the Institute of Cancer Research, London, and the University of Cambridge, took biopsies from patients ...
Scientists track 'doubling' in origin of cancer cells
Medical Xpress· 5 hours ago"An enduring question among scientists in the cancer field is: How do cancer cell genomes get so bad?" says Sergi Regot, Ph.D., associate ...
Novel FOXM1 inhibitor STL001 sensitizes human cancers to a broad-spectrum of cancer therapies - Cell...
Nature· 18 hours agoPharmacological inhibition of FOXM1 could be a promising approach to sensitize therapy-resistant cancers. Here, we explore a novel FOXM1 inhibitor STL001 ...